Showing 61,241 - 61,260 results of 125,008 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((mean decrease) OR (point decrease)) ))', query time: 1.46s Refine Results
  1. 61241

    Silencing of Ribosomal Protein S9 Elicits a Multitude of Cellular Responses Inhibiting the Growth of Cancer Cells Subsequent to p53 Activation by Mikael S. Lindström (110158)

    Published 2010
    “…<div><h3>Background</h3><p>Disruption of the nucleolus often leads to activation of the p53 tumor suppressor pathway through inhibition of MDM2 that is mediated by a limited set of ribosomal proteins including RPL11 and RPL5. …”
  2. 61242
  3. 61243

    Table 1_Early identification of sarcopenia in patients with diabetes mellitus combined with osteoporosis: development and validation of a gender-specific nomogram.docx by Mingzhong Yu (21215879)

    Published 2025
    “…In female patients, body mass index and creatine kinase were associated with a decreased risk of sarcopenia, while age, weight-adjusted waist index, and low-density lipoprotein cholesterol were associated with an increased risk. …”
  4. 61244

    Supplementary Data from HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy by Michael F. Emmons (14935638)

    Published 2023
    “…S1) HDAC expression levels in melanoma cells S2) Cell lines that are resistant to BRAF inhibitors have upregulated c-Jun protein expression S3) Inhibiting HDAC6 does not resensitize BRAF/MEK resistant cells to BRAF inhibitors S4) BRAF/MEK inhibitor withdrawal decreases HDAC8 expression over time S5) Knocking down or elevating HDAC8 levels does not change cell proliferation S6) Expression of HDAC8 increased ERK activity and resistance upon treatment with BRAF-MEK inhibitors S7) Knocking down HDAC8 in BRAFi naïve cells increased apoptosis and BIM expression while decreasing ERK activity after BRAFi activity. …”
  5. 61245
  6. 61246
  7. 61247

    DataSheet1_Real-World Management and Clinical Outcomes of Stroke Survivors With Atrial Fibrillation: A Population-Based Cohort in Spain.docx by Clara L. Rodríguez-Bernal (11829377)

    Published 2021
    “…Regarding temporal trends, management with OAC increased by 20%, with a decrease of 50% for APT during the study period. …”
  8. 61248

    Image 2_Effect of acupuncture on cognitive impairment induced by sleep deprivation in animal models: a preclinical systematic review and meta-analysis.tif by Chang Liu (35901)

    Published 2025
    “…Background<p>Sleep deprivation (SD) has been associated with cognitive deficits, mediated by mechanisms such as neuroinflammation and oxidative stress. Acupuncture, a core component of traditional Chinese medicine, has shown promise in mitigating SD-induced cognitive impairment. …”
  9. 61249

    Table_2_Preoperative Oral Gabapentin in the Management of Postoperative Catheter-Related Bladder Discomfort in Adults: A Systematic Review and Meta-Analysis.docx by Yu-Ting Wang (166811)

    Published 2021
    “…</p><p>Conclusion: Preoperative oral gabapentin as an adjunct to surgery is effective in decreasing the risk and severity of CRBD over a short time after surgery, and it can decrease postoperative pain without significant side effects. …”
  10. 61250

    Image 1_Effect of acupuncture on cognitive impairment induced by sleep deprivation in animal models: a preclinical systematic review and meta-analysis.tif by Chang Liu (35901)

    Published 2025
    “…Background<p>Sleep deprivation (SD) has been associated with cognitive deficits, mediated by mechanisms such as neuroinflammation and oxidative stress. Acupuncture, a core component of traditional Chinese medicine, has shown promise in mitigating SD-induced cognitive impairment. …”
  11. 61251

    Table_1_Preoperative Oral Gabapentin in the Management of Postoperative Catheter-Related Bladder Discomfort in Adults: A Systematic Review and Meta-Analysis.docx by Yu-Ting Wang (166811)

    Published 2021
    “…</p><p>Conclusion: Preoperative oral gabapentin as an adjunct to surgery is effective in decreasing the risk and severity of CRBD over a short time after surgery, and it can decrease postoperative pain without significant side effects. …”
  12. 61252

    Data_Sheet_1_Provenance Differences in Water-Use Efficiency Among Sessile Oak Populations Grown in a Mesic Common Garden.docx by Arivoara Rabarijaona (12984509)

    Published 2022
    “…In response to severe drought, populations with a higher increase in WUE<sub>i</sub> showed a lower decrease in GI. …”
  13. 61253

    Identification of <em>Orch3</em>, a Locus Controlling Dominant Resistance to Autoimmune Orchitis, as Kinesin Family Member 1C by Roxana del Rio (108216)

    Published 2012
    “…These findings may provide mechanistic insight into how polymorphism in other kinesins such as <em>KIF21B</em> and <em>KIF5A</em> influence susceptibility and resistance to human autoimmune diseases.…”
  14. 61254

    Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor by Yuliang Yang (1954498)

    Published 2023
    “…A series of novel ruthenium­(II) and iridium­(III) complexes (<b>Ru1</b>–<b>Ru3</b> and <b>Ir1</b>–<b>Ir3</b>) with different ancillary ligands and a PARP-1-inhibitory chelating ligand 2-(2,3-dibromo-4,5-dimethoxybenzylidene)­hydrazine-1-carbothioamide (<b>L1</b>) were designed and prepared. …”
  15. 61255

    Table2_Preclinical Evidence of Paeoniflorin Effectiveness for the Management of Cerebral Ischemia/Reperfusion Injury: A Systematic Review and Meta-Analysis.DOCX by Anzhu Wang (5501090)

    Published 2022
    “…Paeonia lactiflora Pall. is a commonly used for ischemic stroke management in traditional Chinese medicine; its main active ingredient is paeoniflorin (PF). …”
  16. 61256

    Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor by Yuliang Yang (1954498)

    Published 2023
    “…A series of novel ruthenium­(II) and iridium­(III) complexes (<b>Ru1</b>–<b>Ru3</b> and <b>Ir1</b>–<b>Ir3</b>) with different ancillary ligands and a PARP-1-inhibitory chelating ligand 2-(2,3-dibromo-4,5-dimethoxybenzylidene)­hydrazine-1-carbothioamide (<b>L1</b>) were designed and prepared. …”
  17. 61257

    Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor by Yuliang Yang (1954498)

    Published 2023
    “…A series of novel ruthenium­(II) and iridium­(III) complexes (<b>Ru1</b>–<b>Ru3</b> and <b>Ir1</b>–<b>Ir3</b>) with different ancillary ligands and a PARP-1-inhibitory chelating ligand 2-(2,3-dibromo-4,5-dimethoxybenzylidene)­hydrazine-1-carbothioamide (<b>L1</b>) were designed and prepared. …”
  18. 61258

    Data_Sheet_1_A Novel Promazine Derivative Shows High in vitro and in vivo Antimicrobial Activity Against Staphylococcus aureus.docx by Troels Ronco (414344)

    Published 2020
    “…Surprisingly, in vitro studies showed that the novel compound, JBC 1847 exhibited highly increased antimicrobial activity against eight Gram-positive pathogens (MIC, 0.5–2 mg/L), whereas a disc diffusion assay indicated that the properties as an adjuvant were lost. …”
  19. 61259
  20. 61260

    Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor by Yuliang Yang (1954498)

    Published 2023
    “…A series of novel ruthenium­(II) and iridium­(III) complexes (<b>Ru1</b>–<b>Ru3</b> and <b>Ir1</b>–<b>Ir3</b>) with different ancillary ligands and a PARP-1-inhibitory chelating ligand 2-(2,3-dibromo-4,5-dimethoxybenzylidene)­hydrazine-1-carbothioamide (<b>L1</b>) were designed and prepared. …”